Dr Ryan Haumschild Discusses Payer, Provider Perspectives on Prior Authorization in Rare Diseases
Ryan Haumschild, PharmD, MS, MBA, director of pharmacy at Emory Winship Cancer Institute, shares his unique perspectives as both a provider and payer on the use of prior authorizations (PAs) and "Gold Cards" in patients with rare diseases.
Dr Tariq Cheema Discusses Patient, Family Experiences With Virtual ICU Care
Tariq Cheema, MD, division chair of pulmonary critical care sleep and allergy medicine at Allegheny Health Network (AHN), discusses how the virtual ICU (vICU) program has benefited patients and their families during the COVID-19 pandemic in terms of both patient care and managing resources.
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Catherine Nester Discusses the BeginNGS Tool for Newborn Rare Disease Screening Awareness
Catherine Nester, RN, vice president of physician and patient strategies at Inozyme Pharma, highlights the importance of newborn screening for rare diseases and the impact of the BeginNGS diagnostic tool.